Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Immunology Research"
DOI: 10.1155/2022/8513747
Abstract: Background Neoadjuvant immunotherapy is promising for locally advanced non-small-cell lung cancer (NSCLC). The in situ immune patterns, as a predictor of PD-1/PD-L1 blockade outcomes, of the primary tumor (PT) and metastatic lymph nodes (mLNs) are…
read more here.
Keywords:
situ immune;
tumor;
immune patterns;
neoadjuvant immunotherapy ... See more keywords